Introduction: The association of Heated Tobacco Products (HTPs) use on cancer-related biomarkers remains unclear. This study aimed to compare the levels of tumor markers, specifically alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA), between combustible cigarette (CC) smokers, any HTP users, and quitters.
Methods: This cross-sectional study compared tumor marker levels (AFP, CA 19-9, CEA, PSA) among 750 adult males: 250 CC smokers, 250 any HTP users, and 250 quitters. Data were collected from health screenings (2021-2022). Participants were aged >18 years with at least one year of smoking history.
Results: CEA was significantly higher in CC smokers (median: 2.4) than any HTP users (median: 2.0) and quitters (median: 1.6), with any HTP users exceeding quitters. PSA was higher in any HTP users (median: 0.86) than quitters (median: 0.74). No significant differences were observed in AFP and CA 19-9.
Conclusions: HTP users exhibit lower CEA levels compared to conventional cigarette smokers, yet their levels remain higher than those of quitters. Additionally, quitters were found to have lower PSA levels than HTP users. Further research is needed to determine the reasons for these differences.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11897907 | PMC |
| http://dx.doi.org/10.18332/tid/200890 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Introduction: The association of Heated Tobacco Products (HTPs) use on cancer-related biomarkers remains unclear. This study aimed to compare the levels of tumor markers, specifically alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA), between combustible cigarette (CC) smokers, any HTP users, and quitters.
Methods: This cross-sectional study compared tumor marker levels (AFP, CA 19-9, CEA, PSA) among 750 adult males: 250 CC smokers, 250 any HTP users, and 250 quitters.
Changes in Concentration of Selected Biomarkers of Exposure in Users of Classic Cigarettes, E-Cigarettes, and Heated Tobacco Products-A Narrative Review.
Int J Mol Sci
February 2025
Department of Psychiatry, The Faculty of Medicine, Medical University of Bialystok, 15-272 Bialystok, Poland.
Currently, the number of e-cigarette and heated tobacco product (HTP) users are steadily increasing, while the number of classic cigarette users are decreasing. The effects of smoking classic cigarettes on human health have been thoroughly described in the literature, but the negative health effects of e-cigarettes and HTPs on the human body are not clearly defined. Among users of different forms of tobacco, those at a particularly high risk of developing particular disease entities should be identified, allowing for the faster implementation of potential treatments, including psychotherapeutic ones.
View Article and Find Full Text PDFComparing Cardiovascular Outcomes Among Heated Tobacco Product Users, Cigarette Smokers, Former Smokers, and Never Smokers: Protocol for a Real-World Retrospective Study in Japan.
JMIR Res Protoc
March 2025
PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland, Quai Jeanrenaud 5 - 2000 Neuchâtel, Switzerland, Neuchatel, CH.
Background: Smoking is a known risk factor for cardiovascular diseases (CVD). Despite widespread knowledge of the health risks of combustible cigarettes (CIG), many smokers continue to smoke. There have been efforts to provide alternatives, such as heated tobacco products (HTP), that may be less harmful than CIG.
View Article and Find Full Text PDFChronic Obstructive Pulmonary Disease Outcomes Among Individuals in Japan Who Switched to Heated Tobacco Products Compared to Those Who Continued Smoking or Formerly Smoked Combustible Cigarettes: Protocol for a Real-World Retrospective Study.
JMIR Res Protoc
March 2025
PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland, Quai Jeanrenaud 5 - 2000 Neuchâtel, Switzerland, Neuchatel, CH.
Background: Chronic obstructive pulmonary disease (COPD) is a debilitating respiratory disease that is highly associated with smoking. Despite widespread knowledge of the health risks of smoking, many patients with COPD continue to smoke. Growing evidence suggests that alternatives to combustible cigarettes (CIG), such as heated tobacco products (HTP), may be less harmful.
View Article and Find Full Text PDFComparison of carbonyls and tobacco-specific nitrosamines in aerosols of heated tobacco products and conventional cigarette smoke using both targeted and untargeted analytical methods.
Regul Toxicol Pharmacol
March 2025
Institute of Food Safety and Health Risk Assessment, National Yang Ming Chiao Tung University, Taipei, Taiwan; Kim Forest Enterprise Co., Ltd., Taipei, Taiwan. Electronic address:
Cigarette smoke (CS) exposes users to harmful substances, contributing to chronic lung diseases. Heated tobacco products (HTPs) are marketed as safer alternatives due to their lower toxicant emissions from heating rather than burning tobacco. However, HTPs may produce unique toxicants that are not found in CS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!